increases hyperkalemia risk, especially in patients with chronic kidney disease (CKD), according to findings from a prespecified analysis of the FINEARTS-HF trial (ClinicalTrials.gov Identifier: ...

Hyperkalemia (>5.5 mEq/L ... For congestive heart failure post-myocardial infarction, treatment is initiated at 25 mg once daily and titrated to a target of 50 mg once daily within 4 weeks.

Potassium and renal function must be routinely assessed to minimize the risk of life-threatening hyperkalemia. This review discusses the role of aldosterone antagonists in the treatment of heart ...

Reducing blood pressure could significantly reduce the risk of "major cardiovascular events" for people with type 2 diabetes, ...

The blood pressure study could help doctors treating people with diabetes to reduce the risk of "major cardiovascular events" ...

After hours: January 31 at 4:08:13 PM EST Loading Chart for CTSO ...

Safety and tolerability of different total neoadjuvant therapy strategies in patients with locally advanced rectal cancer. First-in-human, phase 1a, dose escalation study of BGB-B167, a CEA x 4-1BB ...